Previous 10 | Next 10 |
Image source: The Motley Fool. Alcon Inc (NYSE: ALC) Q4 2019 Earnings Call Feb 26, 2020 , 8:00 a.m. ET Operator Continue reading
Alcon, Inc. (ALC) Q4 2019 Results Earnings Conference Call February 26, 2020, 08:00 AM ET Company Participants Karen King - SVP of IR and Communications David Endicott - CEO Tim Stonesifer - CFO Conference Call Participants Anthony Petrone - Jefferies David Lewis - Morgan...
SELLAS Life Sciences Group (NASDAQ: SLS ) +23% on positive follow-up phase 1/2 clinical data for Galinpepimut-S in acute myeloid leukemia. More news on: SELLAS Life Sciences Group, Inc., Alcon, Inc., Moderna, Inc., Stocks on the move, , Read more ...
The following slide deck was published by Alcon, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Alcon (NYSE: ALC ) sees 2020 core EPS of $1.95-$2.05 vs. $2.02 consensus. More news on: Alcon, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...
Alcon (NYSE: ALC ): Q4 Non-GAAP EPS of $0.45 misses by $0.01 ; GAAP EPS of -$0.19 misses by $0.19 . Revenue of $1.88B (+5.0% Y/Y) misses by $10M . Shares +0.8% . Press Release More news on: Alcon, Inc., Earnings news and commentary, Healthcare stocks news,
2019 net sales to third parties up 3%, or 5% constant currency (cc) Third consecutive year of top line growth Generated $920 million in cash from operations and free cash flow of $367 million Full year 2020 outlook: net sales growth of 5% to 6% (cc) and core EPS $...
This article is part of a series that provides an ongoing analysis of the changes made to George Soros's 13F stock portfolio on a quarterly basis. It is based on George Soros's regulatory 13F Form filed on 02/14/2020. Please visit our Tracking Soros Fund Management Holdings article for an ...
The Food and Drug Administration approved three drugs on Friday to switch from prescription status to being available over the counter: GlaxoSmithKline 's (NYSE: GSK) Voltaren Arthritis Pain and two related allergy drugs from Alcon (NYSE: ALC) . The switch, which is typically initiated by...
Now available in the U.S., Pataday® Once Daily Relief is the first and only eye drop to provide all day allergy itch relief without a prescription 1,2 Approximately 66 million Americans who suffer from eye allergies will now have OTC access to long-lasting, prescription-streng...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...